Inception Return
(11/6/1987)
|
7.55 %
|
|
YTD Return
|
5.22 %
|
|
NAVPS
(3/24/2023)
|
$65.44
|
|
Change
|
($0.46) / -0.70 %
|
|
|
Growth of $10,000
(As of February 28, 2023)
|
|
MER
|
1.38 %
|
|
Assets ($mil)
|
-
|
|
Rank (1Yr)
|
560/786
|
|
Std Dev (3Yr)
|
11.57 %
|
|
Volatility Ranking (3Yr)
|
5/10
|
|
RRSP Eligibility
|
Yes
|
|
Load
|
No Load
|
|
Max Front End
|
-
|
|
Max Back End
|
-
|
|
Sales Status
|
Open
|
|
|
Objective
The objectives of this Fund are to achieve above-average long-term, risk-adjusted returns and to provide diversification of risk by investing primarily in entities outside of Canada and the United States. The Fund will be invested primarily in equities and equity-related securities. The amount invested in any one country will vary depending upon the economic, investment, and market outlook and opportunities in each area.
|
Fund Manager
Mawer Investment Management Ltd.
Portfolio Manager
David Ragan, Mawer Investment Management Ltd.
Peter Lampert, Mawer Investment Management Ltd.
Sub-Advisor
Data not available
|
|
Asset Allocation
(As of January 31, 2023)
|
Sector Allocation
(As of January 31, 2023)
|
Geographic Allocation
(As of January 31, 2023)
|
Top 10 Holdings
| Name | Asset | Sector | Geographic | Percent |
| Aon PLC Cl A | International Equity | Financial Services | European Union | 5.64% |
| Wolters Kluwer NV Cl C | International Equity | Industrial Services | European Union | 4.58% |
| Bunzl PLC | International Equity | Industrial Services | European Union | 3.61% |
| Relx PLC | International Equity | Industrial Services | European Union | 3.47% |
| Taiwan Semiconductor Manufactrg Co Ltd | International Equity | Technology | Asia/Pacific Rim | 3.35% |
| LVMH Moet Hennessy Louis Vuitton SE | International Equity | Consumer Goods | European Union | 3.33% |
| Novo Nordisk A/S Cl B | International Equity | Healthcare | European Union | 2.73% |
| Roche Holding AG - Partcptn | International Equity | Healthcare | Other European | 2.38% |
| Deutsche Boerse AG Cl N | International Equity | Financial Services | European Union | 2.30% |
| AstraZeneca PLC | International Equity | Healthcare | European Union | 2.29% |
Performance Data
(As of February 28, 2023)
|
|
Return (%)
|
Annualized Return (%)
|
|
Return
|
1
Mth
|
3
Mth
|
6
Mth
|
YTD
|
1
Yr
|
3
Yr
|
5
Yr
|
10
Yr
|
|
Fund
|
0.88
|
4.88
|
14.74
|
5.22
|
-0.54
|
3.60
|
2.43
|
7.69
|
|
Benchmark
|
-0.51
|
6.39
|
15.32
|
6.11
|
1.85
|
6.86
|
3.37
|
7.87
|
|
Quartile Ranking
|
1
|
2
|
2
|
3
|
3
|
4
|
3
|
2
|
|
Calendar Return (%)
|
2022
|
2021
|
2020
|
2019
|
2018
|
2017
|
2016
|
2015
|
2014
|
2013
|
|
Fund
|
-16.69
|
7.31
|
12.35
|
14.42
|
-4.01
|
22.59
|
-3.24
|
20.27
|
9.12
|
22.57
|
|
Benchmark
|
-10.67
|
8.97
|
8.01
|
16.27
|
-6.81
|
18.37
|
-1.70
|
19.41
|
4.12
|
32.41
|
|
Quartile Ranking
|
4
|
3
|
2
|
3
|
2
|
1
|
3
|
1
|
1
|
4
|